Cardiol Therapeutics (TSE:CRDL) has released an update.
Cardiol Therapeutics Inc. has announced its annual general and special meeting for shareholders on June 26, 2024, where audited financial statements will be presented, directors elected, and auditors appointed. The meeting will be conducted online, allowing shareholders to participate and vote in real-time. Shareholders can access meeting materials electronically or request paper copies via the company’s website or Odyssey Trust Company.
For further insights into TSE:CRDL stock, check out TipRanks’ Stock Analysis page.
